Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-26

Clinical Trial Update: Benefits of Nigella Sativa in Children With Beta Thalassemia Major [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial investigating Nigella Sativa for children with beta-thalassemia major, with the trial status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nigella Sativa (Nigella sativa)

Snippet

Sponsor: Tanta University | Conditions: Nigella Sativa With Beta Thalassemia Major | EARLY_Phase 1 | Status: UNKNOWN